XML 154 R138.htm IDEA: XBRL DOCUMENT v3.19.1
Share-based Payments - Additional Information (Detail)
12 Months Ended
Mar. 31, 2019
USD ($)
yr
$ / shares
shares
Mar. 31, 2018
USD ($)
yr
$ / shares
shares
Mar. 31, 2017
USD ($)
yr
$ / shares
shares
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Number of shares available for future grants | shares 3,303,952    
Number of shares issued upon exercise of share options and RSUs | shares 719,140 1,521,521 906,255
Total cash received from option exercised   $ 1,347,000 $ 8,941,000
Share-based compensation expense $ 30,305,000 30,565,000 23,036,000
2006 Incentive award plan [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Aggregate intrinsic value of options exercised $ 0 $ 180,000 $ 2,697,000
Total grant date fair value of options vested | shares 0 0 0
Total cash received from option exercised $ 0 $ 1,347,000 $ 8,941,000
Number of options granted 0 0 0
Weighted average share price of options exercised $ 0.00 $ 30.44 $ 27.46
Exercise price per options outstanding $ 0 $ 0  
Weighted average remaining contractual term | yr 0 0 0.10
PSUs [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Vesting period   Three years  
Unrecognized compensation cost related to unvested other equity instruments $ 7,055,000    
Weighted average grant date fair value 47.54 $ 30.35 $ 31.12
Aggregate intrinsic value of share units exercised 15,077,000 17,737,000 4,237,000
Total grant date fair value of units vested $ 9,535,000 $ 8,696,000 $ 6,280,000
Weighted average share price of share units exercised other equity instruments | $ / shares $ 50.75 $ 35.01 $ 29.89
Number of other equity instruments issued in share-based payment arrangement 199,303 400,463  
Expected weighted average period for recognition of compensation cost other equity instruments | yr 2.2    
Share-based options [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Share-based incentive plan - term 10 years    
Share-based options [member] | Top of range [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Vesting period Four years    
Restricted share units (RSUs) [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Share-based incentive plan - term 10 years    
Restricted share units (RSUs) [member] | Top of range [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Vesting period Four years    
RSUs dependent on non-market performance condition [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Unrecognized compensation cost related to unvested other equity instruments $ 7,276,000    
Expected weighted average period for recognition of compensation cost other equity instruments | yr 2.7    
Weighted average grant date fair value $ 47.89 $ 30.85 $ 30.26
Aggregate intrinsic value of share units exercised 21,324,000 34,339,000 9,991,000
Total grant date fair value of units vested $ 15,964,000 $ 16,931,000 $ 14,631,000
Weighted average share price of share units exercised other equity instruments | $ / shares $ 50.52 $ 35.73 $ 29.08
Number of other equity instruments issued in share-based payment arrangement 383,229 497,689  
RSUs dependent on market performance condition [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Unrecognized compensation cost related to unvested other equity instruments $ 103,000    
Expected weighted average period for recognition of compensation cost other equity instruments | yr 0.7    
Weighted average grant date fair value $ 0.00 $ 0.00 $ 12.56
Additional cost as a result of modification in respect of modified share awards 1,185,000    
Incremental cost recognized in the current year in respect of such modified RSUs $ 540,000 $ 540,000  
Number of other equity instruments issued in share-based payment arrangement 0 0  
RSUs related total shareholders return [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Unrecognized compensation cost related to unvested other equity instruments $ 4,589,000    
Expected weighted average period for recognition of compensation cost other equity instruments | yr 1.7    
Weighted average grant date fair value $ 57.20 $ 36.52  
Number of other equity instruments issued in share-based payment arrangement 166,760 248,655  
Share-based compensation expense $ 2,886,000 $ 1,368,000  
RSUs BBBEE Program In South Africa [member]      
Disclosure of terms and conditions of share-based payment arrangement [Line Items]      
Vesting period Four years    
Number of other equity instruments issued in share-based payment arrangement 14,250 32,050  
Share-based compensation expense $ 760,000 $ 547,000 $ 0
Unamortized Share based compensation $ 3,040,000